Tagged with

Hungary Prof. Éva Szökő, president of the Hungarian Society for Pharmaceutical Sciences (MGYT), shares her insights on the activities of the society, its collaboration with institutions and industry players in the area of prevention, adherence, public health awareness, translational research, and its future outlook.   [Hungarian] patients are suspicious of prescribed…

Puerto Rico Over the last 22 years, Jorge Rodríguez has grown Puerto Rican industrial automation solutions provider PACIV from a one-man show to an international operator with over 100 employees.   Jorge Rodríguez’s parents were humble immigrants hailing from small villages nestled in the mountains of the Asturias region in Spain. In…

Puerto Rico Headquartered in Tampa, Florida, Romark focuses on developing innovative treatments for infectious diseases and the latest newcomer to Puerto Rico. CEO Marc Ayers recounts how he came to the decision to establish the company’s first manufacturing plant of finished products on the US territory.   What ultimately made the difference…

Asia-Pacific Ai Hua Ong, Asia-Pacific company group chairman of Janssen, the Pharmaceutical Companies of Johnson & Johnson, looks back at the tremendous progress the pharmaceutical industry has made in the Asia-Pacific region over the last ten years and highlights how the industry needs to adapt to meet emergent challenges.   By…

USA Boston University School of Law’s Kevin Outterson* looks at how cost-saving measures are contributing to the rise of drug-resistant “superbugs” in the US and the steps that need to be taken to remedy the situation.   Globally, 700,000 people lose their lives to drug-resistant infections each year In November 2019,…

Opinion Monica Weldon, CEO and president of Bridge the Gap – SYNGAP Education and Research Foundation, shares her recent experience at the US Drug Law and Regulation course in Washington, DC and expands on the role that patient associations can play in the drug development process.   In today’s environment of…

China Michael Zhang, chairman of Peijia Medical, shares Peijia Medical’s mission to become a two-platform medical device company as well as the partner of choice for physicians in China and globally. Peijia Medical’s recent achievements include a Series C round, of over USD 100 million, and the successful completion of clinical…

Russia Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of medications to the patients who need them the most.   An alarming shortage of medicines in Russia is driving some…

Czech Republic The Czech Republic’s Minister of Health,  Adam Vojtěch, is the youngest in the country’s history and has set out an ambitious reform programme to improve the state of the Czech healthcare system.   In my office, I will actively seek to fulfil the key points of my election program –…

Sweden Sweden is fast staking a claim as one of Europe’s premier biotech hotspots thanks to a holistic approach to research projects, a strong institutional ecosystem, and increasingly easy access to funding at the early stages of biotech companies’ development.   Collaboration “The Swedish innovation powerhouse is propelled by our excellent…

Sweden Since going public five years ago, Recipharm, Sweden’s iconic indigenous contract development and manufacturing organization (CDMO), has seen its sales skyrocket by over 30 percent annually. Much of this growth has been driven by an acquisition streak with the company plucking up overseas production assets such as former Roche and…

Sweden Key stakeholders in Swedish pharma explain why Sweden’s record on cancer care is the best in Europe and what more still needs to be done.   National investments in cancer care have improved patient outcomes and reduced waiting times Malin Parkler, Pfizer With an estimated 18 million cases globally in…